Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...

Researchers review current advances in trained immunity—a promising avenue for preventing infectious diseases in chickens ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

The body’s pathogen fighters can act as surveillance forces that ferry information from the gut and fat deposits to the brain ...

Groundbreaking study reveals TR1 cells' crucial role in immune response to malaria, paving way for new vaccines and drugs.

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

Zika virus uses host cell autophagy to suppress antiviral proteins AXL and TIM-1, enhancing its ability to infect without ...

Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

Known for supporting both the innate and adaptive immune systems, vitamin D has long been used to help fend off illness. But ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...